chr1-47030008-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178033.2(CYP4X1):āc.196A>Gā(p.Met66Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,613,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178033.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP4X1 | NM_178033.2 | c.196A>G | p.Met66Val | missense_variant | 2/12 | ENST00000371901.4 | NP_828847.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP4X1 | ENST00000371901.4 | c.196A>G | p.Met66Val | missense_variant | 2/12 | 1 | NM_178033.2 | ENSP00000360968 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251388Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135860
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461790Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 727192
GnomAD4 genome AF: 0.000348 AC: 53AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.000404 AC XY: 30AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.196A>G (p.M66V) alteration is located in exon 2 (coding exon 2) of the CYP4X1 gene. This alteration results from a A to G substitution at nucleotide position 196, causing the methionine (M) at amino acid position 66 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at